Travere Therapeutics Inc (TVTX)
5.455
-0.28
(-4.97%)
USD |
NASDAQ |
Apr 24, 16:00
5.50
+0.04
(+0.82%)
After-Hours: 18:02
Travere Therapeutics EPS Diluted (Quarterly): -1.18 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.18 |
September 30, 2023 | 1.97 |
June 30, 2023 | -1.13 |
March 31, 2023 | -1.27 |
December 31, 2022 | -1.03 |
September 30, 2022 | -1.09 |
June 30, 2022 | -1.05 |
March 31, 2022 | -1.20 |
December 31, 2021 | -0.84 |
September 30, 2021 | -0.59 |
June 30, 2021 | -0.64 |
March 31, 2021 | -0.96 |
December 31, 2020 | -2.37 |
September 30, 2020 | -0.44 |
June 30, 2020 | -0.58 |
March 31, 2020 | 0.02 |
December 31, 2019 | -0.70 |
September 30, 2019 | -0.85 |
June 30, 2019 | -0.92 |
March 31, 2019 | -0.99 |
December 31, 2018 | -0.18 |
September 30, 2018 | -1.34 |
June 30, 2018 | -0.56 |
March 31, 2018 | -0.46 |
December 31, 2017 | -0.55 |
Date | Value |
---|---|
September 30, 2017 | -0.46 |
June 30, 2017 | -0.34 |
March 31, 2017 | -0.32 |
December 31, 2016 | -0.22 |
September 30, 2016 | -1.00 |
June 30, 2016 | -0.37 |
March 31, 2016 | -0.08 |
December 31, 2015 | -0.14 |
September 30, 2015 | 1.78 |
June 30, 2015 | -0.73 |
March 31, 2015 | 1.32 |
December 31, 2014 | -1.18 |
September 30, 2014 | -0.84 |
June 30, 2014 | -0.77 |
March 31, 2014 | -3.25 |
December 31, 2013 | -0.82 |
September 30, 2013 | -0.71 |
June 30, 2013 | -0.41 |
March 31, 2013 | -0.46 |
November 30, 2012 | -0.03 |
August 31, 2012 | -0.03 |
May 31, 2012 | -0.03 |
February 29, 2012 | -0.04 |
November 30, 2011 | -0.03 |
August 31, 2011 | -0.03 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-2.37
Minimum
Dec 2020
1.97
Maximum
Sep 2023
-0.7816
Average
-0.92
Median
Jun 2019
EPS Diluted (Quarterly) Benchmarks
AtriCure Inc | -0.21 |
Bio-Rad Laboratories Inc | 12.14 |
Artivion Inc | -0.10 |
Shockwave Medical Inc | 1.16 |
Perspective Therapeutics Inc | -0.09 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | -90.17M |
Revenue (Quarterly) | 45.06M |
Total Expenses (Quarterly) | 127.90M |
Enterprise Value | 247.22M |
Gross Profit Margin (Quarterly) | 89.87% |
Profit Margin (Quarterly) | -200.1% |
Earnings Yield | -29.51% |
Normalized Earnings Yield | -82.74 |